Variable | Missing, n | All patients (n = 90) | Good outcome (n = 35) | Poor outcome (n = 55) | p value |
---|---|---|---|---|---|
Clinical features | |||||
Age (years) | 0 | 43 (29; 58) | 33 (24; 55) | 45 (34; 58) | 0.04 |
Male sex | 0 | 56 (62.2) | 19 (54.3) | 37 (67.3) | 0.27 |
Immunosuppression | 0 | 41 (45.6) | 12 (34.3) | 29 (52.7) | 0.13 |
Knaus C/D | 0 | 6 (6.7) | 1 (2.9) | 5 (9.1) | 0.40 |
MRC gradea | 0 | 0.06 | |||
1 | 3 (3.3) | 2 (5.7) | 1 (1.8) | ||
2 | 26 (28.9) | 14 (40) | 12 (21.8) | ||
3 | 61 (67.8) | 19 (54.3) | 42 (76.4) | ||
GCS score | 2 | 12 (8; 14) | 14 (10; 14) | 9 (7; 13) | < 0.01 |
Major focal deficit | 0 | 41 (45.6) | 10 (28.6) | 31 (56.4) | 0.02 |
Meningeal syndrome | 0 | 55 (61.1) | 24 (68.6) | 31 (56.4) | 0.28 |
Cranial nerve palsies | 0 | 24 (26.7) | 9 (25.7) | 15 (27.3) | 1.00 |
Seizures | 0 | 31 (34.4) | 9 (25.7) | 22 (40) | 0.18 |
Extraneurological signs | 0 | 62 (68.9) | 21 (60) | 41 (74.5) | 0.17 |
Temperature (°C) | 0 | 38 (37; 39) | 38 (37.5; 39) | 38 (36.9; 39) | 0.53 |
Laboratory findings | |||||
Serum sodium level (mmol/L) | 2 | 131 (127; 135) | 133 (128; 137) | 130 (127; 134) | 0.35 |
CSF pleocytosis (cells/μl)b | 3 | 130 (27; 300) | 140 (36; 350) | 120.5 (27; 250) | 0.56 |
CSF lymphocyte (%)b | 18 | 73.2 (37; 94) | 88.6 (57.1; 96.8) | 59 (33.3; 90) | 0.04 |
CSF glucose level (mmol/L)b | 3 | 2 (1.1; 3) | 2.2 (1.6; 2.6) | 1.9 (1; 3.3) | 0.71 |
CSF protein level (g/L)b | 4 | 1.9 (1; 3) | 1.5 (1.2; 1.9) | 2.3 (0.9; 3.5) | 0.07 |
Brain CT Infarction | 1 | 83 (93.3) | 32 (94.1) | 51 (92.7) | 1.00 |
Infarction | 0 | 12 (14.5) | 0 (0) | 12 (23.5) | < 0.01 |
Hydrocephalus | 0 | 16 (19.3) | 2 (6.3) | 14 (27.5) | 0.02 |
Abscess/tuberculoma | 0 | 19 (22.9) | 9 (28.1) | 10 (19.6) | 0.43 |
Basal arachnoiditis | 0 | 4 (4.8) | 0 (0) | 4 (7.8) | 0.16 |
Brain MRI | 0 | 75 (83.3) | 29 (82.9) | 46 (83.6) | 1.00 |
Infarction | 0 | 38 (50.7) | 9 (31) | 29 (63) | < 0.01 |
Hydrocephalus | 0 | 25 (33.3) | 4 (13.8) | 21 (45.7) | < 0.01 |
Abscess/tuberculoma | 0 | 35 (46.7) | 13 (44.8) | 22 (47.8) | 0.82 |
Basal arachnoiditis | 0 | 37 (49.3) | 13 (44.8) | 24 (52.2) | 0.64 |